About the client
Instem plc is a leading supplier of software solutions to the early development healthcare market. Its solutions are used by organisations, mainly in the pharmaceutical R&D sector, for data collection, management and analysis.
For more than 400 clients around the world, Instem supplies breakthrough technology and services that help efficiently access, capture, manage and enrich a wide array of data.
About the deal
Rickitt Mitchell advised Instem plc on the acquisition of BioWisdom Limited, a provider of software solutions for extracting intelligence from R&D related healthcare data.
The acquisition helped to broaden the data analytics solutions Instem supplies to the healthcare and pharmaceutical industry.
The deal structure included an initial consideration element made up of cash plus theassumption of some unsecured debt and a deferred, contingent consideration element, payable dependent on certain performance criteria being met within a two year period.